Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,006,241 papers from all fields of science
Search
Sign In
Create Free Account
Pergolide Mesylate
Known as:
8beta-[(Methylthio)methyl]-6-propylergoline Monomethanesulfonate
, Pergolide Mesylate [Chemical/Ingredient]
, Pergolide Methanesulfonate
Expand
A semi-synthetic ergot derivative and a dopamine agonist with antiparkinson property. Pergolide mesylate binds to and activates dopamine receptor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Drug Allergy
Ergot Alkaloids
Gilles de la Tourette syndrome
Parkinson Disease
Expand
Narrower (2)
LY-127809
Permax
Broader (1)
Pergolide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Industrial Production of Ergot Alkaloids
Ergot Alkaloids
,
L. Cvak
,
Galena a.s.Opava
2006
Corpus ID: 12590016
This chapter contains information about all the therapeutically used ergot alkaloids and their manufacture. Not all such…
Expand
1996
1996
DETERMINATION OF DISSOLUTION OF PERGOLIDE MESYLATE TABLETS
Hu Ya
1996
Corpus ID: 101182170
The dissolution of pergolide mesylate tablets was determined by small vessel method with HPLC, the RSD was 1.62%, while the…
Expand
1993
1993
Pergolide Mesylate and Physical Performance: A Brief Report
P. Dendale
,
K. D. De Meirleir
1993
Corpus ID: 71647506
We report a study with pergolide mesylate, a dopamine agonist, in healthy men performing a progressive exercise test. A…
Expand
1987
1987
Pergolide mesylate: four years experience in Parkinson's disease.
C. Tanner
,
C. Goetz
,
R. Glantz
,
H. Klawans
Advances in neurology
1987
Corpus ID: 6919792
1987
1987
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
C. Olanow
,
M. J. Alberts
Advances in neurology
1987
Corpus ID: 42693175
1984
1984
The long-acting dopamine agonist pergolide mesylate for treatment of hyperprolactinaemia.
T. Bergh
,
S. J. Nillius
,
L. Wide
Acta Europaea fertilitatis
1984
Corpus ID: 33539490
Seven hyperprolactinaemic women were treated with the new, long-acting dopamine agonist pergolide mesylate. The treatment…
Expand
1983
1983
Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide.
R. Fuller
,
H. Snoddy
,
N. Mason
,
J. Clemens
,
K. Bemis
Neuroendocrinology
1983
Corpus ID: 46854690
Two chemical analogs of pergolide were examined to test further the idea that pergolide elevates serum corticosterone…
Expand
1983
1983
Synthesis and central dopaminergic activities of (+/-)-hexahydro-7H-indolo[3,4-gh][1,4]benzoxazine derivatives [(+/-)-9-oxaergolines].
L. Nedelec
,
A. Pierdet
,
+5 authors
J. Boissier
Journal of Medicinal Chemistry
1983
Corpus ID: 24089455
The synthesis and biological activities of a series of (+/-)-hexahydro-7H-indolo[3,4-gh][1,4]benzoxazine derivatives [(+/-)-trans…
Expand
1982
1982
Reduction in size of prolactin-secreting tumours in men treated with pergolide.
P. Kendall‐Taylor
,
K. Hall
,
D. Johnston
,
R. Prescott
British medical journal
1982
Corpus ID: 23659186
The effect of pergolide mesylate was studied in two previously untreated men with large prolactinomas and exceptionally high…
Expand
1981
1981
Pergolide mesylate: its effects on circulating anterior pituitary hormones in man.
R. L. Perryman
,
A. Rogol
,
D. Kaiser
,
R. Macleod
,
M. Thorner
Journal of Clinical Endocrinology and Metabolism
1981
Corpus ID: 36787342
Pergolide mesylate is a synthetic ergoline with dopamine agonist properties. The endocrine profile was studied in a double blind…
Expand